Erythropoietin - Neose
Alternative Names: GlycoPEG-EPO; GlycoPEGylated erythropoietin - Neose; NE-180Latest Information Update: 31 Oct 2021
At a glance
- Originator Neose Technologies
- Class Antianaemics; Polyethylene glycols; Recombinant erythropoietins; Recombinant fusion proteins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaemia
Most Recent Events
- 01 Feb 2008 Discontinued - Phase-I for Anaemia in Switzerland (IV)
- 01 Feb 2008 Discontinued - Phase-II for Anaemia in Europe (SC)
- 01 Feb 2008 Discontinued - Phase-II for Anaemia in Switzerland (SC)